Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

RainDance Technologies Streamlines Cancer Profiling and Mutation Monitoring with Launch of RainDrop Plus™ Digital PCR System at AMP 2016

RainDance Technologies,Inc.
Posted on: 09 Nov 16

RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the launch of its RainDrop Plus™ Digital PCRSystem featuring faster droplet detection, higher throughput, and new automated analysis capabilities. Maria E. Arcila, MD, at Memorial Sloan Kettering Cancer Center will share her experience with the RainDance products and present recent performance data later today during the RainDance workshop at the Association for Molecular Pathology (AMP) 2016 Annual Meeting.

The RainDrop System is the only unified platform for NGS amplicon enrichment and digital PCR. The proprietary picodroplet technology enables profiling and monitoring cell-free and cell-based biomarkers for variant detection, clonal evolution tracking, and minimal residual disease monitoring applications. By generating millions of highly uniform five picoliter droplet reactions per sample, the RainDrop System delivers superior sensitivity with six log dynamic range. The RainDrop Plus features even faster time to results and new analysis software that streamlines turnaround time, increases throughput, and automates data analysis.

“RainDance has worked closely with our customers in recent years to push the lower limits of detection and achieve levels of sensitivity and precision never before possible,” said Darren Link, PhD, Co-Founder and Chief Technology Officer at RainDance Technologies. “The new RainDrop Plus enables researchers to harness this new level of sensitivity and perform experiments faster and easier than ever before.”

New Product Showcases and Data Presentations

RainDance will showcase its complete line of products at the Association for Molecular Pathology (AMP) 2016 Annual Meeting in Booth 1331 in Charlotte, NC from November 9-12. Dr. Arcila will describe how she is using the RainDance products, including the new RainDrop Plus System, to profile and monitor critical mutations in blood and solid cancers during the company’s lunch workshop on Wednesday, November 9 from 12:00-12:50 p.m. in Room 208A, Charlotte Convention Center. For more information on the company’s activities, please visit

About RainDance Technologies

RainDance Technologies is making complex genetics simple. The company’s proprietary droplet technology enables research in areas such as novel non-invasive liquid biopsy. The ultra-sensitive genomic tools provide more accurate, reliable, and cost-effective detection of genetic variations in cancer, inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment through its international sales and service operations, as well as a global network of distributors and commercial service providers. For more information, please visit

Stay Connected with RainDance Technologies – Complex Genetics Made Simple |

RainDance products are for Research Use Only. Not for use in diagnostic procedures.

RainDance Technologies, the RainDance Technologies logo and ThunderStorm, ThunderBolts, and RainDrop are trademarks of RainDance Technologies, Inc. All other brands may be trademarks of their respective holders.

View source version on

Business Wire

Last updated on: 09/11/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.